General Information of Drug (ID: DMXHWK6)

Drug Name
Neutralase Drug Info
Synonyms Heparinase I, IBEX
Indication
Disease Entry ICD 11 Status REF
Angiogenesis disorder BE2Z Discontinued in Phase 3 [1]
Cross-matching ID
TTD Drug ID
DMXHWK6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Heparanase (HPSE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Suramin DMTOUY9 African trypanosomiasis 1F51 Phase 1 [3]
PG-545 DM68D3O Ocular disease 1F00.1Z Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Heparanase (HPSE) TTR7GJO HPSE_HUMAN Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007559)
2 Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin. J Thromb Haemost. 2006 Mar;4(3):560-5.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1728).
4 PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. Br J Cancer. 2011 Feb 15;104(4):635-42.